{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:07:42Z","timestamp":1793070462925,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00415-019-09461-3","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T10:50:06Z","timestamp":1564483806000},"page":"2743-2751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8359-2886","authenticated-orcid":false,"given":"Kimitoshi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-9640","authenticated-orcid":false,"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"issue":"20","key":"9461_CR1","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","volume":"78","author":"MI Leite","year":"2012","unstructured":"Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78(20):1601\u20131607. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31825644ff","journal-title":"Neurology"},{"issue":"6","key":"9461_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1191\/1352458503ms964oa","volume":"9","author":"CM Isbister","year":"2003","unstructured":"Isbister CM, Mackenzie PJ, Anderson D, Wade NK, Oger J (2003) Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 9(6):550\u2013553. \n                    https:\/\/doi.org\/10.1191\/1352458503ms964oa","journal-title":"Mult Scler"},{"issue":"5","key":"9461_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1212\/01.wnl.0000234142.41728.a0","volume":"67","author":"M Gotkine","year":"2006","unstructured":"Gotkine M, Fellig Y, Abramsky O (2006) Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 67(5):881\u2013883. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000234142.41728.a0","journal-title":"Neurology"},{"issue":"2","key":"9461_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241\u2013255. \n                    https:\/\/doi.org\/10.1002\/ana.23577","journal-title":"Ann Neurol"},{"issue":"2","key":"9461_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"issue":"9","key":"9461_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"issue":"7","key":"9461_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, Kleiter I, Chitnis T (2015) Demographic and clinical features of neuromyelitis optica: a review. Mult Scler 21(7):845\u2013853. \n                    https:\/\/doi.org\/10.1177\/1352458515572406","journal-title":"Mult Scler"},{"issue":"1","key":"9461_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/cen3.12091","volume":"5","author":"H Murai","year":"2014","unstructured":"Murai H, Masuda M, Utsugisawa K, Nagane Y, Suzuki S, Imai T, Motomura M, Konno S, Kira J-i (2014) Clinical features and treatment status of adult myasthenia gravis in Japan. Clin Exp Neuroimmunol 5(1):84\u201391. \n                    https:\/\/doi.org\/10.1111\/cen3.12091","journal-title":"Clin Exp Neuroimmunol"},{"issue":"7","key":"9461_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jocn.2015.01.022","volume":"22","author":"S Blum","year":"2015","unstructured":"Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P (2015) Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci 22(7):1164\u20131169. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2015.01.022","journal-title":"J Clin Neurosci"},{"issue":"6","key":"9461_CR10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1590\/S0004-282X2010000600003","volume":"68","author":"A Aguiar Ade","year":"2010","unstructured":"Aguiar Ade A, Carvalho AF, Costa CM, Fernandes JM, D'Almeida JA, Furtado LE, Cunha FM (2010) Myasthenia gravis in Ceara, Brazil: clinical and epidemiological aspects. Arq Neuropsiquiatr 68(6):843\u2013848","journal-title":"Arq Neuropsiquiatr"},{"key":"9461_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.07.002","volume":"298","author":"A Karni","year":"2016","unstructured":"Karni A, Asmail A, Drory VE, Kolb H, Kesler A (2016) Thymus involvement in myasthenia gravis: epidemiological and clinical impacts of different self-tolerance breakdown mechanisms. J Neuroimmunol 298:58\u201362. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.002","journal-title":"J Neuroimmunol"},{"issue":"6","key":"9461_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00315656","volume":"237","author":"R Mantegazza","year":"1990","unstructured":"Mantegazza R, Beghi E, Pareyson D, Antozzi C, Peluchetti D, Sghirlanzoni A, Cosi V, Lombardi M, Piccolo G, Tonali P et al (1990) A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 237(6):339\u2013344","journal-title":"J Neurol"},{"issue":"12","key":"9461_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/archneurol.2011.200","volume":"68","author":"A Vaknin-Dembinsky","year":"2011","unstructured":"Vaknin-Dembinsky A, Abramsky O, Petrou P, Ben-Hur T, Gotkine M, Brill L, Brenner T, Argov Z, Karussis D (2011) Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle? Arch Neurol 68(12):1557\u20131561. \n                    https:\/\/doi.org\/10.1001\/archneurol.2011.200","journal-title":"Arch Neurol"},{"issue":"9","key":"9461_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12(9):875\u2013884. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2013.03.007","journal-title":"Autoimmun Rev"},{"issue":"1","key":"9461_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2009.12.036","volume":"140","author":"B Kyewski","year":"2010","unstructured":"Kyewski B, Peterson P (2010) Aire, master of many trades. Cell 140(1):24\u201326. \n                    https:\/\/doi.org\/10.1016\/j.cell.2009.12.036","journal-title":"Cell"},{"issue":"5","key":"9461_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/path.2141","volume":"211","author":"P Strobel","year":"2007","unstructured":"Strobel P, Murumagi A, Klein R, Luster M, Lahti M, Krohn K, Schalke B, Nix W, Gold R, Rieckmann P, Toyka K, Burek C, Rosenwald A, Muller-Hermelink HK, Pujoll-Borrell R, Meager A, Willcox N, Peterson P, Marx A (2007) Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 211(5):563\u2013571. \n                    https:\/\/doi.org\/10.1002\/path.2141","journal-title":"J Pathol"},{"issue":"6","key":"9461_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ana.20340","volume":"56","author":"P Strobel","year":"2004","unstructured":"Strobel P, Rosenwald A, Beyersdorf N, Kerkau T, Elert O, Murumagi A, Sillanpaa N, Peterson P, Hummel V, Rieckmann P, Burek C, Schalke B, Nix W, Kiefer R, Muller-Hermelink HK, Marx A (2004) Selective loss of regulatory T cells in thymomas. Ann Neurol 56(6):901\u2013904. \n                    https:\/\/doi.org\/10.1002\/ana.20340","journal-title":"Ann Neurol"},{"issue":"3","key":"9461_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","volume":"149","author":"S Scarpino","year":"2007","unstructured":"Scarpino S, Di Napoli A, Stoppacciaro A, Antonelli M, Pilozzi E, Chiarle R, Palestro G, Marino M, Facciolo F, Rendina EA, Webster KE, Kinkel SA, Scott HS, Ruco L (2007) Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol 149(3):504\u2013512. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03442.x","journal-title":"Clin Exp Immunol"},{"issue":"5\u20136","key":"9461_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3109\/08916930903555935","volume":"43","author":"A Marx","year":"2010","unstructured":"Marx A, Willcox N, Leite MI, Chuang WY, Schalke B, Nix W, Strobel P (2010) Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 43(5\u20136):413\u2013427. \n                    https:\/\/doi.org\/10.3109\/08916930903555935","journal-title":"Autoimmunity"},{"issue":"3","key":"9461_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.humimm.2011.12.022","volume":"73","author":"A Holbro","year":"2012","unstructured":"Holbro A, Jauch A, Lardinois D, Tzankov A, Dirnhofer S, Hess C (2012) High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol 73(3):287\u2013290. \n                    https:\/\/doi.org\/10.1016\/j.humimm.2011.12.022","journal-title":"Hum Immunol"},{"issue":"1","key":"9461_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.1017","volume":"50","author":"C Buckley","year":"2001","unstructured":"Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N (2001) Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 50(1):64\u201372","journal-title":"Ann Neurol"},{"issue":"7","key":"9461_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S1474-4422(07)70132-1","volume":"6","author":"SV Ramagopalan","year":"2007","unstructured":"Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC (2007) Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6(7):604\u2013610. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(07)70132-1","journal-title":"Lancet Neurol"},{"key":"9461_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90\u2013100. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2013.12.011","journal-title":"J Autoimmun"},{"issue":"2","key":"9461_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","volume":"105","author":"A Balandina","year":"2005","unstructured":"Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S (2005) Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105(2):735\u2013741. \n                    https:\/\/doi.org\/10.1182\/blood-2003-11-3900","journal-title":"Blood"},{"issue":"1\u20132","key":"9461_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneuroim.2010.07.016","volume":"227","author":"KH Chan","year":"2010","unstructured":"Chan KH, Kwan JS, Ho PW, Ho SL, Chui WH, Chu AC, Ho JW, Zhang WY, Kung MH (2010) Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis. J Neuroimmunol 227(1\u20132):178\u2013184. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.016","journal-title":"J Neuroimmunol"},{"issue":"12","key":"9461_CR26","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41582-018-0095-7","volume":"14","author":"AE Handel","year":"2018","unstructured":"Handel AE, Irani SR, Hollander GA (2018) The role of thymic tolerance in CNS autoimmune disease. Nat Rev Neurol 14(12):723\u2013734. \n                    https:\/\/doi.org\/10.1038\/s41582-018-0095-7","journal-title":"Nat Rev Neurol"},{"issue":"5 Pt 1","key":"9461_CR27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0091-6749(99)70431-8","volume":"103","author":"R Gerli","year":"1999","unstructured":"Gerli R, Paganelli R, Cossarizza A, Muscat C, Piccolo G, Barbieri D, Mariotti S, Monti D, Bistoni O, Raiola E, Venanzi FM, Bertotto A, Franceschi C (1999) Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 103(5 Pt 1):865\u2013872","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"9461_CR28","first-page":"S57","volume":"6","author":"L Speciale","year":"2000","unstructured":"Speciale L, Saresella M, Caputo D, Ruzzante S, Mancuso R, Calvo MG, Guerini FR, Ferrante P (2000) Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J Neurovirol 6(Suppl 2):S57\u201361","journal-title":"J Neurovirol"},{"issue":"2","key":"9461_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0022-510X(99)00082-9","volume":"165","author":"H Harada","year":"1999","unstructured":"Harada H, Tamaoka A, Kohno Y, Mochizuki A, Shoji S (1999) Exacerbation of myasthenia gravis in a patient after interferon-beta treatment for chronic active hepatitis C. J Neurol Sci 165(2):182\u2013183","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"9461_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-5728(98)00191-X","volume":"92","author":"A Miller","year":"1998","unstructured":"Miller A, Shapiro S, Gershtein R, Kinarty A, Rawashdeh H, Honigman S, Lahat N (1998) Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2\/Th3 immune-deviation. J Neuroimmunol 92(1\u20132):113\u2013121","journal-title":"J Neuroimmunol"},{"issue":"17","key":"9461_CR31","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMra1100030","volume":"365","author":"JH Cho","year":"2011","unstructured":"Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365(17):1612\u20131623. \n                    https:\/\/doi.org\/10.1056\/NEJMra1100030","journal-title":"N Engl J Med"},{"key":"9461_CR32","doi-asserted-by":"publisher","first-page":"541760","DOI":"10.1155\/2012\/541760","volume":"2012","author":"M Testi","year":"2012","unstructured":"Testi M, Terracciano C, Guagnano A, Testa G, Marfia GA, Pompeo E, Andreani M, Massa R (2012) Association of HLA-DQB1*05:02 and DRB1*16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis. Autoimmune Dis 2012:541760. \n                    https:\/\/doi.org\/10.1155\/2012\/541760","journal-title":"Autoimmune Dis"},{"issue":"1","key":"9461_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","volume":"84","author":"S Yoshimura","year":"2013","unstructured":"Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, Kawano Y, Kira J (2013) Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 84(1):29\u201334. \n                    https:\/\/doi.org\/10.1136\/jnnp-2012-302925","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9461_CR34","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41467-018-04332-3","volume":"9","author":"K Estrada","year":"2018","unstructured":"Estrada K, Whelan CW, Zhao F, Bronson P, Handsaker RE, Sun C, Carulli JP, Harris T, Ransohoff RM, McCarroll SA, Day-Williams AG, Greenberg BM, MacArthur DG (2018) A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica. Nature Commun 9(1):1929. \n                    https:\/\/doi.org\/10.1038\/s41467-018-04332-3","journal-title":"Nature Commun"},{"issue":"5","key":"9461_CR35","doi-asserted-by":"publisher","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","volume":"7","author":"AH Maniaol","year":"2012","unstructured":"Maniaol AH, Elsais A, Lorentzen AR, Owe JF, Viken MK, Saether H, Flam ST, Brathen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. PLoS ONE 7(5):e36603. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0036603","journal-title":"PLoS ONE"},{"issue":"10","key":"9461_CR36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023\u20131036. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"issue":"6","key":"9461_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS (2012) Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11(6):535\u2013544. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70133-3","journal-title":"Lancet Neurol"},{"issue":"8","key":"9461_CR38","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/brain\/awy109","volume":"141","author":"S Binks","year":"2018","unstructured":"Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR (2018) Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain 141(8):2263\u20132271. \n                    https:\/\/doi.org\/10.1093\/brain\/awy109","journal-title":"Brain"},{"issue":"3","key":"9461_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, Hoftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J (2014) Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 75(3):411\u2013428. \n                    https:\/\/doi.org\/10.1002\/ana.24117","journal-title":"Ann Neurol"},{"issue":"6","key":"9461_CR40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/art.1780270616","volume":"27","author":"M Goldman","year":"1984","unstructured":"Goldman M, Herode A, Borenstein S, Zanen A (1984) Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis Rheum 27(6):701\u2013703","journal-title":"Arthritis Rheum"},{"issue":"1","key":"9461_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1212\/WNL.33.1.97","volume":"33","author":"R Lo","year":"1983","unstructured":"Lo R, Feasby TE (1983) Multiple sclerosis and autoimmune diseases. Neurology 33(1):97\u201398","journal-title":"Neurology"},{"issue":"3","key":"9461_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0165-5728(83)90032-2","volume":"4","author":"RA Shakir","year":"1983","unstructured":"Shakir RA, Hussien JM, Trontelj JV (1983) Myasthenia gravis and multiple sclerosis. J Neuroimmunol 4(3):161\u2013165","journal-title":"J Neuroimmunol"},{"key":"9461_CR43","doi-asserted-by":"crossref","unstructured":"Balarabe SA, Adamu MD, Watila MM, Jiya N (2015) Neuromyelitis optica and myasthenia gravis in a young Nigerian girl. BMJ Case Rep. \n                    https:\/\/doi.org\/10.1136\/bcr-2014-207362","DOI":"10.1136\/bcr-2014-207362"},{"issue":"1","key":"9461_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mus.21197","volume":"39","author":"A McKeon","year":"2009","unstructured":"McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ (2009) Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39(1):87\u201390. \n                    https:\/\/doi.org\/10.1002\/mus.21197","journal-title":"Muscle Nerve"},{"issue":"3","key":"9461_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/01658107.2013.879903","volume":"38","author":"GS Yau","year":"2014","unstructured":"Yau GS, Lee JW, Chan TT, Yuen CY (2014) Neuromyelitis optica spectrum disorder in a Chinese woman with ocular myasthenia gravis: first reported case in the Chinese population. Neuroophthalmology 38(3):140\u2013144. \n                    https:\/\/doi.org\/10.3109\/01658107.2013.879903","journal-title":"Neuroophthalmology"},{"issue":"1","key":"9461_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/S0004-282X2008000100002","volume":"66","author":"DB Bichuetti","year":"2008","unstructured":"Bichuetti DB, Barros TM, Oliveira EM, Annes M, Gabbai AA (2008) Demyelinating disease in patients with myasthenia gravis. Arq Neuropsiquiatr 66(1):5\u20137","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"9461_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/NRL.0b013e318247bc91","volume":"18","author":"K Ogaki","year":"2012","unstructured":"Ogaki K, Hirayama T, Chijiiwa K, Fukae J, Furuya T, Noda K, Fujishima K, Hattori N, Takahashi T, Okuma Y (2012) Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis. Neurologist 18(2):76\u201379. \n                    https:\/\/doi.org\/10.1097\/NRL.0b013e318247bc91","journal-title":"Neurologist"},{"issue":"1\u20132","key":"9461_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jns.2009.08.040","volume":"287","author":"A Uzawa","year":"2009","unstructured":"Uzawa A, Mori M, Iwai Y, Kobayashi M, Hayakawa S, Kawaguchi N, Kuwabara S (2009) Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis. J Neurol Sci 287(1\u20132):105\u2013107. \n                    https:\/\/doi.org\/10.1016\/j.jns.2009.08.040","journal-title":"J Neurol Sci"},{"issue":"6","key":"9461_CR49","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1212\/01.WNL.0000115168.73299.88","volume":"62","author":"JC Antoine","year":"2004","unstructured":"Antoine JC, Camdessanche JP, Absi L, Lassabliere F, Feasson L (2004) Devic disease and thymoma with anti-central nervous system and antithymus antibodies. Neurology 62(6):978\u2013980","journal-title":"Neurology"},{"issue":"4","key":"9461_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","volume":"60","author":"JI O'Riordan","year":"1996","unstructured":"O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60(4):382\u2013387","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9461_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5692\/clinicalneurol.50.111","volume":"50","author":"Masayuki Kohsaka","year":"2010","unstructured":"Kohsaka M, Tanaka M, Tahara M, Araki Y, Mori S, Konishi T (2010) A case of subacute myelitis with anti-aquaporin 4 antibody after thymectomy for myasthenia gravis: review of autoimmune diseases after thymectomy. Rinsho Shinkeigaku 50(2):111\u2013113","journal-title":"Rinsho Shinkeigaku"},{"issue":"8","key":"9461_CR52","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/1352458511431728","volume":"18","author":"S Jarius","year":"2012","unstructured":"Jarius S, Paul F, Franciotta D, de Seze J, Munch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler 18(8):1135\u20131143. \n                    https:\/\/doi.org\/10.1177\/1352458511431728","journal-title":"Mult Scler"},{"issue":"3","key":"9461_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000334128","volume":"3","author":"M Etemadifar","year":"2011","unstructured":"Etemadifar M, Abtahi SH, Dehghani A, Abtahi MA, Akbari M, Tabrizi N, Goodarzi T (2011) Myasthenia gravis during the course of neuromyelitis optica. Case Rep Neurol 3(3):268\u2013273. \n                    https:\/\/doi.org\/10.1159\/000334128","journal-title":"Case Rep Neurol"},{"issue":"6","key":"9461_CR54","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1468-1331.2006.01392.x","volume":"13","author":"Y Furukawa","year":"2006","unstructured":"Furukawa Y, Yoshikawa H, Yachie A, Yamada M (2006) Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur J Neurol 13(6):655\u2013658. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01392.x","journal-title":"Eur J Neurol"},{"issue":"6","key":"9461_CR55","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archneur.63.6.851","volume":"63","author":"I Kister","year":"2006","unstructured":"Kister I, Gulati S, Boz C, Bergamaschi R, Piccolo G, Oger J, Swerdlow ML (2006) Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 63(6):851\u2013856. \n                    https:\/\/doi.org\/10.1001\/archneur.63.6.851","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"9461_CR56","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jns.2008.06.038","volume":"275","author":"CS Kay","year":"2008","unstructured":"Kay CS, Scola RH, Lorenzoni PJ, Jarius S, Arruda WO, Werneck LC (2008) NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 275(1\u20132):148\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.jns.2008.06.038","journal-title":"J Neurol Sci"},{"issue":"16","key":"9461_CR57","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1212\/01.wnl.0000262954.51568.25","volume":"68","author":"B. G. Weinshenker","year":"2007","unstructured":"Ikeda K, Araki Y, Iwasaki Y (2007) Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 68(16):1326 (author reply 1327)","journal-title":"Neurology"},{"key":"9461_CR58","unstructured":"Hironishi M, Ishimoto S, Sawanishi T, Miwa H, Kawachi I, Kondo T (2012) Neuromyelitis optica following thymectomy with severe spinal cord atrophy after frequent relapses for 30 years. Brain Nerve 64(8):951\u2013955"},{"issue":"7","key":"9461_CR59","doi-asserted-by":"publisher","first-page":"503","DOI":"10.5692\/clinicalneurol.52.503","volume":"52","author":"Tomoaki Tsujii","year":"2012","unstructured":"Tsujii T, Nishikawa N, Tanabe N, Iwaki H, Nagai M, Nomoto M (2012) Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report. Rinsho Shinkeigaku 52(7):503\u2013506","journal-title":"Rinsho Shinkeigaku"},{"key":"9461_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clineuro.2014.07.036","volume":"125","author":"R Ikeguchi","year":"2014","unstructured":"Ikeguchi R, Shimizu Y, Suzuki S, Shimizu S, Kabasawa C, Hashimoto S, Masuda M, Nagane Y, Utsugisawa K, Suzuki Y, Takahashi T, Utsumi H, Fujihara K, Suzuki N, Uchiyama S (2014) Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. Clin Neurol Neurosurg 125:217\u2013221. \n                    https:\/\/doi.org\/10.1016\/j.clineuro.2014.07.036","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"9461_CR61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000117285","volume":"36","author":"MR Tola","year":"1996","unstructured":"Tola MR, Casetta I, Granieri E, Caniatti LM, Monetti VC, Pascarella R (1996) Systemic lupus erythematosus related recurrent transverse myelitis in a patient with myasthenia gravis and multiple sclerosis. Eur Neurol 36(5):327\u2013328","journal-title":"Eur Neurol"},{"key":"9461_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.msard.2018.12.028","volume":"28","author":"VC Bibic","year":"2018","unstructured":"Bibic VC, Brust TB, Burton JM (2018) Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases. Mult Scler Relat Disord 28:125\u2013128. \n                    https:\/\/doi.org\/10.1016\/j.msard.2018.12.028","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"9461_CR63","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4103\/0028-3886.57817","volume":"57","author":"K Basiri","year":"2009","unstructured":"Basiri K, Etemadifar M, Maghzi AH, Zarghami N (2009) Frequency of myasthenia gravis in multiple sclerosis: report of five cases from Isfahan, Iran. Neurol India 57(5):638\u2013640. \n                    https:\/\/doi.org\/10.4103\/0028-3886.57817","journal-title":"Neurol India"},{"key":"9461_CR64","doi-asserted-by":"publisher","first-page":"291731","DOI":"10.1155\/2011\/291731","volume":"2011","author":"K Gharagozli","year":"2011","unstructured":"Gharagozli K, Shojaei M, Harandi AA, Akbari N, Ilkhani M (2011) Myasthenia gravis development and crisis subsequent to multiple sclerosis. Case Rep Med 2011:291731. \n                    https:\/\/doi.org\/10.1155\/2011\/291731","journal-title":"Case Rep Med"},{"issue":"7","key":"9461_CR65","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp.2003.028233","volume":"75","author":"J Dionisiotis","year":"2004","unstructured":"Dionisiotis J, Zoukos Y, Thomaides T (2004) Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment. J Neurol Neurosurg Psychiatry 75(7):1079","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"9461_CR66","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s004150070118","volume":"247","author":"A Frese","year":"2000","unstructured":"Frese A, Bethke F, Ludemann P, Stogbauer F (2000) Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate. J Neurol 247(9):713","journal-title":"J Neurol"},{"issue":"6","key":"9461_CR67","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1212\/WNL.49.6.1747-a","volume":"49","author":"G Blake","year":"1997","unstructured":"Blake G, Murphy S (1997) Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment. Neurology 49(6):1747\u20131748","journal-title":"Neurology"},{"issue":"2","key":"9461_CR68","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/BF02173310","volume":"226","author":"Wayne W. Bixenman","year":"1988","unstructured":"Bixenman WW, Buchsbaum HW (1988) Multiple sclerosis, euthyroid restrictive Grave's ophthalmopathy, and myasthenia gravis. A case report. Graefe's Arch Clin Exp Ophthalmol 226(2):168\u2013171","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"1\u20132","key":"9461_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jneuroim.2013.08.016","volume":"264","author":"J Sylvester","year":"2013","unstructured":"Sylvester J, Purdie G, Slee M, Gray JX, Burnet S, Koblar S (2013) Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: a case report and literature review. J Neuroimmunol 264(1\u20132):130\u2013133. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2013.08.016","journal-title":"J Neuroimmunol"},{"issue":"13","key":"9461_CR70","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1212\/WNL.0000000000006251","volume":"91","author":"L Midaglia","year":"2018","unstructured":"Midaglia L, Gratacos M, Caronna E, Raguer N, Sastre-Garriga J, Montalban X, Tintore M (2018) Myasthenia gravis following alemtuzumab therapy for multiple sclerosis. Neurology 91(13):622\u2013624. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000006251","journal-title":"Neurology"},{"issue":"1","key":"9461_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-510X(89)90005-1","volume":"89","author":"Hannu Somer","year":"1989","unstructured":"Somer H, Muller K, Kinnunen E (1989) Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings. J Neurol Sci 89(1):37\u201348","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"9461_CR72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.410320319","volume":"32","author":"JW Lindsey","year":"1992","unstructured":"Lindsey JW, Albers GW, Steinman L (1992) Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Ann Neurol 32(3):407\u2013409. \n                    https:\/\/doi.org\/10.1002\/ana.410320319","journal-title":"Ann Neurol"},{"key":"9461_CR73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 998:413\u2013423","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"9461_CR74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12974-016-0533-7","volume":"13","author":"J Koge","year":"2016","unstructured":"Koge J, Hayashi S, Murai H, Yokoyama J, Mizuno Y, Uehara T, Ueda N, Watanabe O, Takashima H, Kira J (2016) Morvan's syndrome and myasthenia gravis related to familial Mediterranean fever gene mutations. J Neuroinflammation 13(1):68. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0533-7","journal-title":"J Neuroinflammation"},{"issue":"2","key":"9461_CR75","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11060-010-0130-z","volume":"99","author":"C Briani","year":"2010","unstructured":"Briani C, Cagnin A, Blandamura S, Altavilla G (2010) Multiple paraneoplastic diseases occurring in the same patient after thymomectomy. J Neurooncol 99(2):287\u2013288. \n                    https:\/\/doi.org\/10.1007\/s11060-010-0130-z","journal-title":"J Neurooncol"},{"issue":"3","key":"9461_CR76","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10072-009-0041-y","volume":"30","author":"C Rinaldi","year":"2009","unstructured":"Rinaldi C, Russo CV, Filla A, De Michele G, Marano E (2009) Course and outcome of a voltage-gated potassium channel antibody negative Morvan\u2019s syndrome. Neurol Sci 30(3):237\u2013239. \n                    https:\/\/doi.org\/10.1007\/s10072-009-0041-y","journal-title":"Neurol Sci"},{"issue":"7","key":"9461_CR77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ncpneuro0526","volume":"3","author":"J Diaz-Manera","year":"2007","unstructured":"Diaz-Manera J, Rojas-Garcia R, Gallardo E, Juarez C, Martinez-Domeno A, Martinez-Ramirez S, Dalmau J, Blesa R, Illa I (2007) Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 3(7):405\u2013410. \n                    https:\/\/doi.org\/10.1038\/ncpneuro0526","journal-title":"Nat Clin Pract Neurol"},{"issue":"2","key":"9461_CR78","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.22297","volume":"69","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, Peles E, Scherer SS, Dalmau J (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69(2):303\u2013311. \n                    https:\/\/doi.org\/10.1002\/ana.22297","journal-title":"Ann Neurol"},{"issue":"2","key":"9461_CR79","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/jnnp.2009.174888","volume":"82","author":"A Sadnicka","year":"2011","unstructured":"Sadnicka A, Reilly MM, Mummery C, Brandner S, Hirsch N, Lunn MP (2011) Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis. J Neurol Neurosurg Psychiatry 82(2):230\u2013232. \n                    https:\/\/doi.org\/10.1136\/jnnp.2009.174888","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"9461_CR80","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.65.6.857","volume":"65","author":"EK Lee","year":"1998","unstructured":"Lee EK, Maselli RA, Ellis WG, Agius MA (1998) Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 65(6):857\u2013862","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9461_CR81","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.0b013e3182061b1e","volume":"76","author":"I Rubio-Agusti","year":"2011","unstructured":"Rubio-Agusti I, Perez-Miralles F, Sevilla T, Muelas N, Chumillas MJ, Mayordomo F, Azorin I, Carmona E, Moscardo F, Palau J, Jacobson L, Vincent A, Vilchez JJ, Bataller L (2011) Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology 76(2):172\u2013178. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182061b1e","journal-title":"Neurology"},{"issue":"23","key":"9461_CR82","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1212\/WNL.0000000000002037","volume":"85","author":"C Laurencin","year":"2015","unstructured":"Laurencin C, Andre-Obadia N, Camdessanche JP, Mauguiere F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P (2015) Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome. Neurology 85(23):2076\u20132078. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002037","journal-title":"Neurology"},{"issue":"1","key":"9461_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/NRL.0000000000000097","volume":"22","author":"M Nagappa","year":"2017","unstructured":"Nagappa M, Mahadevan A, Sinha S, Bindu PS, Mathuranath PS, Bineesh C, Bharath RD, Taly AB (2017) Fatal Morvan syndrome associated with myasthenia gravis. Neurologist 22(1):29\u201333. \n                    https:\/\/doi.org\/10.1097\/NRL.0000000000000097","journal-title":"Neurologist"},{"issue":"13","key":"9461_CR84","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1212\/WNL.0000000000003778","volume":"88","author":"E Torres-Vega","year":"2017","unstructured":"Torres-Vega E, Mancheno N, Cebrian-Silla A, Herranz-Perez V, Chumillas MJ, Moris G, Joubert B, Honnorat J, Sevilla T, Vilchez JJ, Dalmau J, Graus F, Garcia-Verdugo JM, Bataller L (2017) Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis. Neurology 88(13):1235\u20131242. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003778","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09461-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09461-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09461-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T23:16:16Z","timestamp":1595459776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09461-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9461"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09461-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all the authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All studies in this review have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}